| Symbol | ALMOF |
|---|---|
| Name | ALPHAMAB ONCOLOGY |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | - |
| Address | China HK Room 1901, 19/F, Lee Garden One 33 Hysan Avenue |
| Telephone | +86 512 6285 0800 |
| Fax | — |
| — | |
| Website | https://www.alphamabonc.com/en/ |
| Incorporation | CN |
| Incorporated On | 2008 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | NOT AVAILABLE |
| Reporting Status | International Reporting: Hong Kong Stock Exchange |
| CIK | — |
| Description | Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacture, and commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. Additional info from OTC: |
No news found.